Quebec City’s Medicago in race for COVID-19 vaccine

4120_medicago man.png
Photo: Medicago

Michael Schunk is the vice-president of operations for Medicago.

A Quebec City company is a serious contender in the race to develop a vaccine to combat COVID-19. Medicago, a biopharmaceutical company founded in 1999, has already produced a virus-like particle (VLP) that mimics the new coronavirus now wreaking havoc in the world.